GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.

Ryan Hogg

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss&#8217;s current pay didn’t reward her performance and would put off future candidates from becoming Walmsley’s successor.<div class="paywall-selector"></div><div class="paywall">



The British pharma giant released a remuneration plan this week that could make Walmsley one of the FTSE100’s highest-paid CEOs, provided she can help GSK’s share price soar and oversee a host of successful new drug rollouts.



According to GSK’s 2024 remuneration report, Walmsley was paid £10.6 million ($13.3 million) in 2024. Under the remuneration committee’s proposals, Walmsley’s total pay package could reach up to eight times her base salary.



The remuneration committee’s proposal will go before shareholders in May.



“The CEO’s current package, which is currently in the lower quartile of the new size-adjusted global biopharma peer group, is insufficient either to reward her performance, or to provide the appropriate capacity for succession,” Wendy Becker, the chair of GSK’s remuneration committee, wrote in the report.



As is regular practice, Walmsley’s pay will only hit that magic $27 million figure if a number of performance targets are hit over the next three years. Only 16% of Walmsley’s 2024 pay was attributable to her base salary.



Walmsley, who has headed up GSK since 2017, will be set the task of increasing GSK’s share price by 50% and helping the group launch several drugs.&nbsp;



If Walmsley hits those targets, she would be paid more than Pascal Soriot, the boss of GSK’s close competitor AstraZeneca and the <a href="https://highpaycentre.org/ftse-100-ceo-pay-reaches-new-high/">highest-paid CEO</a> on the FTSE100. In its remuneration report, the committee said that because of GSK’s operations, it was not appropriate to compare Walmsley’s salary with the rest of the British stock index.



The group is also the benchmark against which it judges CEO compensation to only include pharmaceutical groups, having previously included retailers like Adidas and Unilever.



“The proposed changes to our executive remuneration policy further strengthen the link between management and shareholder interests, with higher rewards contingent on industry-leading R&amp;D progress and shareholder returns,” a spokesperson for GSK told Fortune.



The U.K.’s biggest companies have been on a mission to hike the salaries of their CEOs amid fears they could lose out on the best talent.&nbsp;



Last year, AstraZeneca proposed a pay packet that could reach up to £25.2 million ($31.2 million) for its CEO Pascal Soriot, with some investors arguing he was being “massively underpaid”.



Soriot’s proposed remuneration plan passed despite significant opposition from shareholders, a third of whom rejected the proposal.</div>

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

GSK could double CEO Emma Walmsley's pay to $27 million

Emma Walmsley, chief executive officer of GlaxoSmithKline speaks during the Clinton Global Initiative annual meeting in New York City on September 24, 2024.

F-BreakingNews

Health

Leadership

Success

GSK could double CEO Emma Walmsley's pay to $27 million | Fortune Europe

Richard Eisenberg

If you’re not happy with your Medicare Advantage plan, experts offer these tips to find better benefits

/well/article/medicare-advantage-plan-find-better-benefits/

Alexa Mikhail

McDonald’s CEO shares 3 food trends driving his business: ‘Protein is hot’

/well/article/mcdonalds-ceo-predictions-restaurant-industry/

Beth Greenfield

A woman wearing a head wrap gets a vaccine from a masked doctor

Early mRNA vaccine trial results show potential breakthrough in fighting one of the deadliest cancers

/well/2025/02/27/pancreatic-cancer-mrna-vaccine-clinical-trial/

Devi Shastri

The Associated Press

First U.S. measles death in over a decade: Unvaccinated child dies of virus in Texas outbreak that’s infected more than 120 people

/well/2025/02/26/first-measles-death-west-texas-outbreak-infections-vaccine/

The unexpected aging clues hidden in your nails, according to 3 dermatologists

/well/article/aging-clues-hidden-nails-dermatologists/

Woman with long red hair at kitchen sink filling up water bottle

The truth about American drinking water: Report shows widespread presence of hazardous chemicals

/well/2025/02/26/drinking-water-hazardous-chemicals/

Fortune Editors

Fortune Europe provides smart and timely business news in European markets.

Uncategorized

homepage

Fortune Europe

Finance

Lifestyle

Retail

Tech

Jason Ma

The US economy has suddenly been thrown into reverse as key GDP indicator flashes stunning negative forecast

https://fortune.com/2025/03/01/us-economy-recession-outlook-q1-gdp-contraction-trump-tariffs-doge-job-cuts-consumer-spending-inflation/?itm_source=parsely-api

Lila MacLellan

Six years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $75 million

https://fortune.com/2025/03/01/23andme-buy-back-attempt-board-experts-shareholder-questions-anne-wojcicki/?itm_source=parsely-api

After Trump-Zelensky blowup, Europe may be more willing to seize frozen Russian assets while EU official says 'free world needs a new leader'

https://fortune.com/2025/03/01/europe-seizure-frozen-russian-assets-ukraine-war-trump-zelensky/?itm_source=parsely-api

Russia's old economy is gone, and its wartime transformation has the military primed for a resurgence, former State Dept. official warns

https://fortune.com/2025/03/02/russia-economy-transformation-putin-military-ukraine-war-sanctions-peace-deal/?itm_source=parsely-api

HR Brew

Asking employees to come back to the office like the old days is the same as trying to 'jam the toothpaste back in the tube,' workforce strategist says

https://fortune.com/2025/02/28/asking-employees-to-rto-same-as-trying-to-jam-the-toothpaste-back-in-the-tube/?itm_source=parsely-api

As Stellantis posts 70% profit plunge, fresh inventory data suggests U.S. price cuts may be working

https://fortune.com/europe/2025/02/28/stellantis-posts-profit-plunge-fresh-inventory-data-suggests-us-price-cuts-may-be-working/?itm_source=parsely-api